PHARMACOSMOS HOLDING A/S: Financial statements 2023
CVR: 69720919
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
PHARMACOSMOS HOLDING A/S (CVR 69720919) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 30,638,000 and a net result of DKK 128,644,000 compared with DKK 184,436,000 the year before. That is an increase of 30.1% compared with the year before. The profit margin was 419.9%. Equity in the 2023 report amounted to DKK 1,031,422,000. The solvency ratio was 98%. The company had 532 employees in the financial year.
- Revenue
- DKK 30,638,000
- Gross Profit
- DKK 24,492,000
- Profit/Loss
- DKK 128,644,000
- Equity
- DKK 1,031,422,000
- Total Assets
- DKK 1,052,477,000
- Employees
- 532
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 30.6M | 24.5M | 128.6M | 1B | 532 |
| 2022 | 23.6M | 17.8M | 184.4M | 969.9M | 468 |
| 2021 | 2.7M | -722K | -124M | 790.9M | 352 |
| 2020 | 2.7M | -51K | 50.7M | 940.1M | 258 |
| 2019 | 2.8M | 205K | 97.2M | 888.7M | 236 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 8, 2023, Henrik Parker has joined the board of directors of PHARMACOSMOS HOLDING A/S.
As of December 8, 2023, Robert Guglielmetti has left the board of directors of PHARMACOSMOS HOLDING A/S.
As of December 8, 2023, Henrik Parker is registered as director of PHARMACOSMOS HOLDING A/S.
As of December 8, 2023, Robert Guglielmetti has stepped down as director of PHARMACOSMOS HOLDING A/S.
About PHARMACOSMOS HOLDING A/S
PHARMACOSMOS HOLDING A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1965. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named PHARMACOSMOS A/S. The management consists of Tobias Sidelmann Christensen and Henrik Parker. The board consists of Lars Christensen (chair), Henrik Parker and Milena Jordanova Olsen. The company is owned by Medicosmos A/S. The company has 1 employee (2022). In 2026, the company reported revenue of DKK 63,000,000 and a net result of DKK 756,000,000 compared with DKK 1,652,000,000 the year before. Equity in the 2026 report amounted to DKK 3,044,000,000.
